Topic: How To Invest

Power Growth Investor Hotline – Friday, July 26, 2024

Article Excerpt

BOSTON SCIENTIFIC CORP., $74.92, is a buy. The company (symbol BSX on New York) develops and markets medical devices used in minimally invasive procedures. Its products are used for angioplasty (blood vessel repair), blood clot filtration, cardiac rhythm management, catheter-aided ultrasound imaging, and many other surgical procedures. It generates 60% of its sales in the U.S. and 40% internationally. In the three months ended June 30, 2024, Boston Scientific’s revenue rose 14.5%, to $4.12 billion from $3.60 billion a year earlier. Excluding one-time items, the company earned $914.0 million, or $0.62 a share. That was up 17.4% from $777.0 million, or $0.53. Boston Scientific is now buying Silk Road Medical, Inc. (symbol SILK on Nasdaq) for $1.16 billion. That firm is a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease. It does this through a minimally invasive procedure called transcarotid artery revascularization (TCAR). Carotid artery disease is the cause of one-third of…